Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  AUSTRALIAN SECURITIES EXCHANGE LIMITED  >  Cellmid Limited    CDY   AU000000CDY3

CELLMID LIMITED

(CDY)
End-of-day quote. End-of-day quote AUSTRALIAN SECURITIES EXCHANGE LIMITED - 11/24
0.38 AUD   -5.00%
04/01CELLMID : Alopecia Patent allowed in Europe
PU
03/25CELLMID : Investor Newsletter March 2019
PU
02/21CELLMID : Appendix 4D, Half Year Accounts and Strategy Update
PU
 SummaryChartsNewsCalendarCompany 
Company
Cellmid Limited develops and markets therapies and diagnostic tests for inflammatory and fibrotic diseases, cancer, ischemic diseases of the heart, and hair loss. The Company operates in two segments: research and development of diagnostics and therapeutics, and research, development and marketing... 
More about the company
Latest news on CELLMID LIMITED
04/01CELLMID : Alopecia Patent allowed in Europe
PU
03/25CELLMID : Investor Newsletter March 2019
PU
02/21CELLMID : Appendix 4D, Half Year Accounts and Strategy Update
PU
02/06CELLMID : Significant New Findings Published On MIDKINE
PU
01/22CELLMID : Appendix 4C and Notes to Appendix 4C
PU
2018CELLMID : Investor Newsletter - December 2018_Not announced on ASX
PU
2018CELLMID : CDY- Cellmid Expects Record Sales in Q2 FY2019
PU
2018CELLMID : CDY - Cellmid Appoints Exclusive New Zealand Distributor
PU
2018CELLMID : CDY - Change of Directors Interest Notice - Halasz
PU
2018CELLMID : CDY - Change of Directors Interest Notice - Eck
PU
More news
Sector news : Biotechnology & Medical Research - NEC
08/22GSK's long acting HIV injection gets boost from study
RE
08/15European Medicines Agency Reviews Arthritis Treatment by Gilead, Galapagos
DJ
08/12REGENERON PHARMACEUTICALS : Two Experimental Ebola Drugs Reduce Mortality Rate
DJ
08/08Sarepta says adverse event report for DMD gene therapy erroneously submitted
RE
08/08AGENUS : FDA Accepts AGEN2373 IND, Triggering $7.5 Million Milestone
DJ
More sector news : Biotechnology & Medical Research - NEC
Chart CELLMID LIMITED
Duration : Period :
Cellmid Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Managers
NameTitle
Maria Julianna Halasz Chief Executive Director & Managing Director
David William King Non-Executive Chairman
Joseph Haklani Vice President-Operations
Graham Robertson Head-Research & Development
Fintan Walton Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
CELLMID LIMITED-26.92%12
IQVIA HOLDINGS INC31.83%30 001
LONZA GROUP37.53%26 603
INCYTE CORPORATION28.81%17 616
CELLTRION, INC.--.--%15 955
EXACT SCIENCES CORPORATION85.36%15 145